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Abstract
Purpose Laparoscopic hiatal hernia repair with additional
fundoplication is a commonly recommended standard
surgical treatment for symptomatic large hiatal hernias
with paraesophageal involvement (PEH). However, due to
the risk of persistent side effects, this method remains
controversial. Laparoscopic mesh-augmented hiatoplasty
without fundoplication (LMAH), which combines hiatal
repair and mesh reinforcement, might therefore be an
alternative.
Methods In this retrospective study of 55 (25 male, 30
female) consecutive PEH patients, the perioperative course
and symptomatic outcomes were analyzed after a mean
follow-up of 72 months.
Results The mean DeMeester symptom score decreased
from 5.1 to 1.8 (P \ 0.001) and the gas bloating value
decreased from 1.2 to 0.5 (P = 0.001). The dysphagia
value was 0.7 before surgery and 0.6 (P = 0.379) after
surgery. The majority of the patients were able to belch and
vomit (96 and 92 %, respectively). Acid-suppressive ther-
apy on a regular basis was discontinued in 68 % of
patients. In 4 % of patients, reoperation was necessary due
to recurrent or persistent reflux. A mesh-related stenosis
that required endoscopic dilatation occurred in 2 % of
patients.
Conclusions LMAH is feasible, safe and provides an
anti-reflux effect, even without fundoplication. As opera-
tion-related side effects seem to be rare, LMAH is a
potential treatment option for large hiatal hernias with
paraesophageal involvement.
Keywords Gastroesophageal reflux disease  Anti-reflux
surgery  Laparoscopic mesh-augmented hiatoplasty 
Fundoplication  Mesh reinforcement
Introduction
Laparoscopic fundoplication (LF) is recommended as an
adjunct to the surgical treatment of symptomatic large
hiatal hernias with paraesophageal involvement (PEH) [1–
3]. However, there are a number of undesirable fundopli-
cation-related side effects, such as gas bloating and dys-
phagia, which occur in up to 58 % of patients [4, 5]. Due to
the presence of persistent side effects in about 20 % of
patients, it is necessary to investigate whether PEH could
be surgically treated without an additional fundoplication
[6, 7]. An investigation of a simple laparoscopic mesh-
augmented hiatoplasty without an additional fundoplica-
tion (LMAH) could answer this question.
Whether an adequate anti-reflux effect of LMAH can be
achieved will depend on the reconstruction of the hiatus
and the durable fixation of the esophagogastric junction
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below the diaphragm by mesh reinforcement, thereby
lengthening the abdominal part of the esophagus. The latter
is an important criterion for ensuring an adequate function
of the lower esophageal sphincter [8].
The major problem associated with simple hiatoplasties
in combination with some type of cardiopexy is that, while
they provide a good anti-reflux effect in up to 90 % of
cases, they have reflux recurrence rates of 60 % in the long
term [9–11]. Styger et al. [3] have also shown that after
repair of PEH without fundoplication, there was a new
onset of gastroesophageal reflux in 32 % of patients.
Consequently, cardiopexy procedures have been rejected in
favor of fundoplication. However, all of these data origi-
nated from the time before mesh augmentation at the hiatus
was used to prevent recurrences of hiatal hernias and the
consequent gastroesophageal reflux. Therefore, recurrences
after LMAH may be prevented by mesh augmentation even
without additional fundoplication.
The aim of the present retrospective cohort study was to
evaluate the feasibility, safety and efficiency of LMAH in
terms of reflux control, side effects and recurrences after
the treatment of PEH.
Methods
Patients
In the present retrospective follow-up study, the records of
55 consecutive patients who underwent LMAH for the
repair of PEH at Bad Saulgau Hospital between July 1999
and July 2006 were reviewed for details on the perioper-
ative course and the outcome after a long-term follow-up.
All patients gave their informed consent. The patient
characteristics are summarized in Table 1.
Preoperative assessment
Preoperatively, the patients were investigated for the type
of hiatal hernia with an upper-gastrointestinal endoscopy in
47 (86 %) cases and/or a barium swallow in 39 (71 %)
cases. Only large hiatal hernias defined as hernias with
paraesophageal involvement (PEH) were included in the
present study. Additionally, the patients were screened for
evidence of gastroesophageal reflux disease (GERD),
which was present in a total of 38 (69 %) patients, as
confirmed by upper-gastrointestinal endoscopy in 28
(74 %) patients, by barium swallow in five (13 %) patients,
by symptomatic voluminous reflux in three (8 %) patients
and by a positive proton pump inhibitor test in two (5 %)
patients. If apparent, esophagitis was graded according to
the Savary and Miller or Los Angeles classification [12,
13]. The details of the hernias are given in Table 2. The
main symptoms leading to the operation are summarized in
Table 3.
Surgical technique
All procedures were performed as described previously
[14]. All herniated structures were first repositioned
(Fig. 1a). After incision of the lesser omentum and the
peritoneum at the hiatus, the hernia sac was completely
reduced. To identify the esophagus, a 32 Fr esophageal
bougie was used. After complete mobilization of the hernia
sac and the distal esophagus, the hiatus was narrowed with
three to four non-absorbable, multifilament sutures
Table 1 Patient characteristics (n = 55)
Gender (male/female) 25/30
Age in years ± SD (range) 61 ± 13 (37–84)
BMI in kg/m2 ± SD (range) 29 ± 4 (22–44)




SD standard deviation, BMI body mass index, ASA American Society
of Anesthesiologists Score
Table 2 Results of preoperative upper-gastrointestinal endoscopy
(n = 47)
Esophagitis n (%)
LA A/SM I 8 (17)
LA B/SM II 4 (9)
LA C/SM III 4 (9)
LA D/SM IV 8 (17)
Unspecified 6 (13)
Negative 17 (36)
Barrett’s esophagus 8 (17)
Stenosis 0 (0)
Ulcus 2 (4)
LA Los Angeles classification, SM Savary–Miller classification






Cardiopulmonary symptoms 6 (11)
GERD gastroesophageal reflux disease
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(Fig. 1b), and a circular 8 9 8 cm heavyweight (85 g/m2)
polypropylene mesh (SurgiproTM, Tyco Healthcare,
Neustadt, Germany) was applied from behind around the
esophagus and fixed with 8–12 staples (Endo UniversalTM
65; Tyco Healthcare, Neustadt, Germany) towards the dia-
phragm (Fig. 1c). Finally, an anterior cardiophrenicopexy
was routinely added with 5–7 non-absorbable, multifilament
sutures (Fig. 1d).
Follow-up assessment
Forty-one of the 55 (75 %) patients were available for an
objective follow-up (barium swallow and/or an upper-gas-
trointestinal endoscopy) after an average of 73 ± 26 (range
26–109) months. All patients received a standardized
questionnaire (symptomatic follow-up), which was
answered by 50 (91 %) patients after a mean of 72 ± 26
(range 25–109) months either by mail (n = 40), phone
(n = 4) or during a follow-up examination (n = 6). All the
questions focused on the time before the operation as well
as the state at the time of the survey. The questionnaire
included questions on reflux symptoms, such as heartburn
and regurgitation, as well as side effects, such as dysphagia
and gas bloating. The patients could rate their symptoms as
none = 0, mild = 1, moderate = 2 and severe = 3. By
adding up the values for heartburn, regurgitation and dys-
phagia, the DeMeester symptom score [15] was calculated.
The total score ranged from 0 (no symptoms) to 9 (maximal
symptoms). Treatment failure was defined according to the
definition used by Lundell et al. [16]. One of the following
criteria, therefore, had to be present: moderate or severe
heartburn, moderate or severe acid regurgitation, esopha-
gitis of at least grade II, the requirement of daily proton
pump inhibitor (PPI) treatment or the need for reoperation
because of GERD. Additionally, the symptomatic outcome
was classified according to the modified Visick score
(I = no symptoms; II = mild symptoms, no regular medi-
cation or physician’s help needed; III = significant symp-
toms, regular medication or physician’s help needed;
IV = symptoms as bad as or worse than before surgery)
[17]. The patients were asked whether they were able to
belch and vomit, if they needed continuous PPI therapy, if
endoscopy was necessary for any reason and if they had
undergone a reoperation. Furthermore, the assessment
included questions on the surgical success and the patients’
physical state. Finally, the patients were asked how satisfied
they were with their surgical results and whether they would
be willing to undergo the operation again.
Statistical analysis
The statistical analysis was performed using the SPSS 11.5
software program (SPSS Inc., Chicago, IL). The following
tests were used: the Chi-square test or the Fisher exact test,
as appropriate, for nominal data, and the Mann–Whitney
U test and the Wilcoxon signed-rank test for comparisons
of unrelated and related nonparametric data, respectively.
The Spearman rank correlation was used for the correlation
analysis. A two-sided P value \0.05 was considered to be
statistically significant.
Fig. 1 The laparoscopic mesh-
augmented hiatoplasty.
a Repositioning of all herniated
structures, mobilization of the
hernia sac and the distal
esophagus. b Crurorraphy: the
hiatus is narrowed with 3–4
non-absorbable, multifilament
sutures. c A circular 8 9 8 cm
heavyweight polypropylene
mesh is applied from behind
around the esophagus, and fixed
with staples towards the
diaphragm. d An anterior
cardiophrenicopexy is routinely
added




The mean length of the LMAH operation was 104 ± 67
(range 35–375) min. There was one (2 %; 95 % CI
0.3–13.0 %) intraoperative complication, with no need for
conversion to open surgery. The patient had a gastric perfo-
ration, which had to be treated with a gastric wedge resection.
Four of 55 (7 %; 95 % CI 2.4–17.7 %) patients had postop-
erative complications, including transient dysphagia (n = 2),
delayed gastric emptying (n = 1) and a urinary tract infection
(n = 1). The mortality rate was zero (95 % CI 0–7.8 %). The
mean hospital stay was 8 ± 4 (range 4–25) days.
Long-term follow-up
Re-interventions and objective outcome
Using upper-gastrointestinal endoscopy, esophagitis and
Barrett’s esophagus were each confirmed in three of 17
patients (18 %; 95 % CI 5.4–41.8 %). A sliding hiatal
hernia was present in four of 41 patients, as confirmed by
barium swallow and/or upper-gastrointestinal endoscopy,
corresponding to an anatomical recurrence rate of 10 %
(95 % CI 3.3–23.1 %). In three of 50 (6 %; 95 % CI
1.4–16.8 %) patients, a re-intervention was necessary. Two
(4 %) of them were laparoscopically reoperated with the
addition of a fundoplication due to reflux symptoms, and
one needed endoscopic dilatation due to stenosis of the
esophagus with severe dysphagia.
Symptomatic outcome
The DeMeester symptom score decreased from a preop-
erative score of 5.1 ± 2.1 to 1.8 ± 2.0 (P \ 0.001) post-
operatively. The reflux value decreased from 2.3 ± 0.9 to
0.6 ± 0.9 (P \ 0.001).
According to the definition used by Lundell et al. [16],
17 of 50 (34 %; 95 % CI 22.4–47.9 %) patients showed a
failure of reflux treatment. The details are given in Table 4.
Sixteen of the 50 (32 %; 95 % CI 20.7–45.9 %) patients
needed daily PPI treatment on a regular basis due to reflux
symptoms. Regarding the side effects, the dysphagia value
hardly changed, from 0.7 ± 1 to 0.6 ± 0.9 (P = 0.379). In
terms of the gas bloating, a decrease was documented from
1.2 ± 1.2 to 0.5 ± 0.8 (P = 0.001). Two of the 50 (4 %;
95 % CI 0.3–14.2 %) patients who were available for
follow-up reported an inability to belch, and four (8 %;
95 % CI 2.6–19.4 %) patients were unable to vomit.
According to the Visick score, 19 of 50 (38 %) were
classified as type I, 10 (20 %) patients as type II, 18 (36 %)
patients as type III and 3 (6 %) patients as type IV.
Patients’ assessments
Forty of the 50 (80 %; 95 % CI 66.8–88.9 %) patients were
satisfied with the result and would undergo LMAH again.
Forty-one (82 %; 95 % CI 69.0–90.4 %) assessed the
surgical result to be good or better, and 44 (88 %; 95 % CI
75.8–94.8 %) reported an improved physical state after
LMAH. For details see Table 5.
Discussion
This study was planned to evaluate the feasibility, safety
and efficiency of LMAH as a method to treat PEH without
an additional fundoplication. In our study, the procedure
could be performed at a reasonable time of 104 min on
average. One (2 %) patient who had a gastric perforation
without the need for conversion experienced complications
during the surgical treatment. In our patient series, post-
operative morbidity was observed in 7 % of patients and no
postoperative mortality occurred. After an average of
72 months, 90 % of patients no longer had a PEH and two-
thirds of patients were free of reflux symptoms. This is in
line with the results of another prospective cohort study
that was recently published by the last author. In that study,
conducted at the cantonal hospital of St. Gallen/
Table 4 Failure of reflux treatment as defined by Lundell et al. [16]
(n = 50)
Criterion n (%) 95 % CI
Moderate or severe heartburn 10 (20) 11.15–33.2
Moderate or severe acid regurgitation 7 (14) 6.65–26.5
Esophagitis of at least grade II 2 (4) 0.35–14.2
Requirement of daily PPI treatment 16 (32) 20.75–45.9
Need for reoperation because of GERD 2 (4) 0.35–14.2
Total number of patients fulfilling at least one
of the above criteria
17 (34) 22.4–47.9
PPI proton pump inhibitor, GERD gastroesophageal reflux disease
Table 5 Outcomes of patients available for follow-up 73 months





n (%) Satisfaction n (%)
Excellent 10 (20) Normalized 22 (44) Very satisfied 25 (50)
Very good 15 (30) Improved 22 (44) Satisfied 16 (32)
Good 16 (32) Unchanged 6 (12) Unsatisfied 7 (14)
Sufficient 5 (10) Worsened 0 (0) Very
unsatisfied
0 (0)
Insufficient 3 (6) No response 2 (4)
No response 1 (2)
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Switzerland, a significant decrease of reflux symptoms was
shown 1 year postoperatively, with a recurrence rate of
9 % [14]. Thus, LMAH appears to be feasible and safe and
to have an anti-reflux effect, even without fundoplication.
Based on the past and present experiences, it appears
that an anti-reflux procedure during PEH repair is neces-
sary to prevent hernia recurrence and postoperative gas-
troesophageal reflux. Allison [18] reviewed 421 of his own
patients following hiatal hernia repair by hiatoplasty
without fundoplication. Twenty-two years later, hiatal
hernias or the presence of reflux were radiologically con-
firmed in 49 % after sliding hiatal hernia repair, and in
33 % after PEH repair. Styger et al. [3] reported a new
occurrence of reflux in 32 % of patients after a repair of
PEH without fundoplication, an observation which was
also confirmed by other authors [19, 20]. On the other
hand, in a non-randomized comparative study, Williamson
et al. [7] presented a nearly identical reflux rate of 19 %
without and 16 % with fundoplication. However, in both
studies, the presence of a selection bias cannot be ruled out.
The uncertainty regarding the need for a fundoplication in
the repair of PEH is also illustrated by the fact that dif-
ferent patient groups, despite consistent fundoplication,
have had postoperative reflux rates of 8–15 % [21–24]. In
addition, in contrast to other patient groups, in which the
fundoplication was only performed in patients with proven
reflux, postoperative reflux was observed in 2–10 % of
patients [25–29].
However, all of the publications mentioned above date
to the time before mesh patches were available for rein-
forcement at the hiatus. In our opinion, the option of mesh
augmentation at the hiatus, which has been proven to
reduce the recurrence of hiatal hernias, justifies a re-eval-
uation of the need for a fundoplication during PEH repair
[23, 30, 31]. Allison [18] reported a steady increase in
recurrences in the years following simple hiatoplasties. In
contrast, upon evaluating 306 patients following LMAH
for GERD and sliding hiatal hernias, we observed no
increase in the treatment failure after the first year [32].
The overall rate of anatomical hernia recurrence was 10 %
in the present study. Recurrence rates of up to 42 % were
seen with simple, primary suture repair of the hiatus in the
previous studies [1, 31, 33]. Therefore, we feel that con-
sistent mesh application is the best way to prevent recur-
rences after PEH repair, and that the procedure can be
successful in the majority of cases, even without
fundoplication.
Notably, the anti-reflux effect of LMAH does not appear
to be as good as that of LF. In our study, one-third of the
patients showed a failure of the treatment according to the
definition provided by Lundell et al. [16], and two of these
patients decided to undergo a reoperation due to reflux
symptoms. When a reoperation is demanded because of
persistent or new-onset GERD, we propose that fundopli-
cation should be added to LMAH as a second-step proce-
dure, as was done in the two patients who underwent
reoperations in our cohort. Thus, a combination of LMAH
and fundoplication seems to be the best option for the
surgical treatment of PEH in terms of prevention of ana-
tomical recurrence and postoperative reflux. However, the
question remains whether the results are better with an
additional fundoplication in terms of side effects and
quality of life. This issue can only be resolved by future
randomized controlled trials.
In our study, about 80 % of the patients were satisfied
with their results, and almost 90 % reported that their
condition had improved or normalized. About 80 % of the
patients would undergo this operation again, and referred to
the outcome of LMAH as good as or better than before the
surgery. Regarding the side effects of LMAH, a significant
decrease in gas bloating after surgery was noted. Only 8 %
of patients were not able to vomit after surgery, and 4 % of
patients reported that they could not belch. In studies with
the main focus on side effects in the long-term follow-up
after fundoplication, rates of gas bloating of 34 and 60 %,
and rates of the inability to belch of 29 and 74 % were
reported [4, 6, 34]. Similarly, more than 20 % of the
patients were found to be unable to belch in the study
reported by Lundell et al. [16]. Therefore, it can be
assumed that LMAH has less negative effects, such as gas
bloating, in comparison to LF. Regarding dysphagia, we
found that 8 % of patients had serious complaints in our
series without fundoplication. This value is not surprising,
since dysphagia is a common problem associated with all
forms of hiatoplasty, which is generally performed in
combination with a fundoplication. In agreement with this,
Granderath et al. [35] stated that dysphagia is more a
problem of the narrowing of the hiatus than of the fundo-
plication itself. Consequently, it cannot be expected that
the problem of dysphagia will be completely resolved by
LMAH, but it could possibly be reduced by using cali-
bration tubes larger than the 32 Fr tubes used in the present
study.
LMAH implies that there is consistent mesh application
at the hiatus. Therefore, one important factor to consider is
mesh-related complications, such as erosions, migrations
and stenoses. In our study, only one (2 %) patient experi-
enced a relevant mesh-related complication, which was a
stenosis of the esophagus that could be endoscopically
dilated. Stadlhuber et al. [36] published a case series
identifying 28 patients with mesh-related complications
after hiatal repair. However, the true rate of mesh-related
complications is unknown. Pooling all Medline-listed
patient series from 1997 until 2009 with at least one mesh-
related complication (n = 2392), 22 mesh-related compli-
cations were reported [32, 33, 37–42]. This correlates to a
824 Surg Today (2014) 44:820–826
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mesh-related complication rate of 0.9 %. In accordance
with this finding, Targarona et al. [43] considered mesh
reinforcement at the hiatus to be a safe procedure.
In summary, LMAH is a feasible and safe method to treat
PEH. It seems that a durable anatomical reconstruction and
a certain anti-reflux effect can also be achieved without
fundoplication, with the benefit of fewer side effects.
However, the procedure also has some drawbacks, such as
the persistence or new onset of reflux and the risk of dys-
phagia. It is currently not possible to draw a final conclusion
as to whether a fundoplication during PEH repair is nec-
essary or not. Nevertheless, the present results warrant a
randomized controlled trial evaluating the need for a fun-
doplication during mesh-augmented PEH repair in terms of
reflux control, patient satisfaction and quality of life.
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